• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】12330

【品名】methyl 4-(acetamido)-2-hydroxybenzoate

【CA登记号】

【 分 子 式 】C10H11NO4

【 分 子 量 】209.20168

【元素组成】C 57.41% H 5.3% N 6.7% O 30.59%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(I)

The starting compounds (IV) and (VII) are obtained as follows: a) Methyl 4-acetylamino-2-hydroxybenzoate (I) is converted to the 2-ethoxy derivative (II) with ethyl iodide, and then chlorination of (II) with N-chlorosuccinimide followed by alkaline hydrolysis of (III) gives benzoic acid (IV). b) The reaction of 2-[(4-fluorobenzyl)amino]ethanol (V) with N-(2,3-epoxypropyl)phthalimide (VI), followed by treatment with concentrated sulfuric acid, affords intermediate (VII). The condensation of 4-Amino-5-chloro-2-ethoxybenzoic acid (IV) with 4-(4-fluorobenzyl)-2-(methylamino) morpholine (VII) by means of ethyl chloroformate and triethylamine in CHCl3 gives 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl] benzamide, which is converted to mosapride citrate, by treatment with citric acid.

1 Kato, S.; Yoshida, N.; Ito, T.; Mosapride Citrate. Drugs Fut 1993, 18, 6, 513.
2 Kato, S.; Morie, T.; Hino, K.; Kon, T.; Naruto, S.; Yoshida, N.; Karasawa, T.; Matsumoto, J.; Novel benzamides as selective and potent gastrokinetic agents. 1. Synthesis and structure-activity relationships of N[4-(2-morpholinyl)alkyl]benzamides. J Med Chem 1990, 33, 5, 1406-13.
3 Kato, S.; Morie, T.; Hino, K.; Kon, T.; Naruto, S.; Yoshida, N.; Karasawa, T.; Matsumoto, J.; Novel benzamides as selective and potent gastrokinetic agents. 1. Synthesis and structure-activity relationships of N[4-(2-morpholinyl)alkyl]benzamides. J Med Chem 1990, 33, 5, 1406-13.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12330 methyl 4-(acetamido)-2-hydroxybenzoate C10H11NO4 详情 详情
(II) 12331 Methyl 4-acetamido-2-ethoxybenzoate; methyl 4-(acetamido)-2-ethoxybenzoate 59-06-3 C12H15NO4 详情 详情
(III) 12332 methyl 4-(acetamido)-5-chloro-2-ethoxybenzoate C12H14ClNO4 详情 详情
(IV) 12333 4-Amino-5-chloro-2-ethoxybenzoic acid C9H10ClNO3 详情 详情
(V) 12334 2-[(4-Fluorobenzyl)amino]-1-ethanol C9H12FNO 详情 详情
(VI) 12335 2-(2-Oxiranylmethyl)-1H-isoindole-1,3(2H)-dione; N-(2,3-Epoxypropyl)phtalimide 5455-98-1 C11H9NO3 详情 详情
(VII) 12336 [4-(4-Fluorobenzyl)-1,4-oxazinan-2-yl]methylamine; [4-(4-Fluorobenzyl)-1,4-oxazinan-2-yl]methanamine; 2-Aminomethyl-4-(4-fluorobenzyl)morpholine 112914-13-3 C12H17FN2O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

Alkylation of methyl 4-(acetylamino)-2-hydroxybenzoate (I) with propargyl bromide (II) in the presence of K2CO3 in refluxing acetonitrile gave propargyl ether (III), and subsequent chlorination with N-chlorosuccinimide in DMF yielded (IV). Then, a Claisen-type rearrangement of (IV) in boiling diphenyl ether furnished the benzopyran (V), which was hydrogenated over Pt/C to give dihydrobenzopyran (VI). Subsequent treatment of (VI) with 4 N KOH produced the hydrolysis of both ester and amide functions, affording acid (VII). Treatment of dicyclopropyl ketone (VIII) with HCl gas provided 1,7-dichloro-4-heptanone (IX). Cyclization of (IX) with cyanoacetic acid in a two-phase system of aqueous ammonia and n-hexane gave bicyclic intermediate (X), which upon decarboxylation yielded nitrile (XI). Subsequent hydrogenation in the presence of Raney-Ni and NaOH furnished 5-(2-aminoethyl)-1-azabicyclo[3.3.0]octane (XII) (3). The title compound was then obtained by coupling of acid (VII) with amine (XII) using carbonyldiimidazole (CDI), followed by conversion to the hemifumarate salt.

1 Kakigami, T.; et al.; Synthesis and structure-activity relationship of 3-substituted benzamide, benzo[b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-7-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists. Chem Pharm Bull 1998, 46, 1, 42.
2 Suzuki, T.; et al.; N-[2-(1-Azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline, a potent muscarinic agonist. Chem Pharm Bull 1997, 45, 7, 1218.
3 Kakigami, T.; et al.; A 3D-quantitative structure-activity relationship study of benzamide type serotonin 5-HT4 receptor agonists based on a comparative molecular field analysis model, and the design and synthesis of potent agonists. Chem Pharm Bull 1998, 46, 12, 1881.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12330 methyl 4-(acetamido)-2-hydroxybenzoate C10H11NO4 详情 详情
(II) 11176 3-Bromopropyne; 3-Bromo-1-propyne 106-96-7 C3H3Br 详情 详情
(III) 19907 methyl 4-(acetamido)-2-(2-propynyloxy)benzoate C13H13NO4 详情 详情
(IV) 19908 methyl 4-(acetamido)-5-chloro-2-(2-propynyloxy)benzoate C13H12ClNO4 详情 详情
(V) 19909 methyl 5-(acetamido)-6-chloro-2H-chromene-8-carboxylate C13H12ClNO4 详情 详情
(VI) 19910 methyl 5-(acetamido)-6-chloro-8-chromanecarboxylate C13H14ClNO4 详情 详情
(VII) 19911 5-amino-6-chloro-8-chromanecarboxylic acid C10H10ClNO3 详情 详情
(VIII) 19912 Dicyclopropylmethanone; Dicyclopropyl ketone 1121-37-5 C7H10O 详情 详情
(IX) 19913 1,7-dichloro-4-heptanone 40624-07-5 C7H12Cl2O 详情 详情
(X) 19914 2-cyano-2-tetrahydro-1H-pyrrolizin-7(5H)-ylacetic acid C10H14N2O2 详情 详情
(XI) 19915 2-tetrahydro-1H-pyrrolizin-7(5H)-ylacetonitrile C9H14N2 详情 详情
(XII) 19916 2-tetrahydro-1H-pyrrolizin-7(5H)-ylethylamine; 2-tetrahydro-1H-pyrrolizin-7(5H)-yl-1-ethanamine C9H18N2 详情 详情
Extended Information